Babson Diagnostics
Chris Tanzi previously served as Senior Vice President of Global Marketing with Siemens Healthineers where he led the Central Laboratory Solutions Franchise Group. Chris’ responsibilities spanned portfolio strategy, product management and marketing for in vitro diagnostic products accounting for over $2 billion of annual revenue for Siemens. During his 10 years with Siemens, Chris also headed the Strategic Planning team across the organization. Prior to joining Siemens, Chris led Global Molecular Market Development with Immucor, a Transfusion and Transplant diagnostics company.
Chris holds a BSE in Chemical Engineering from the School of Engineering and Applied Sciences of the University of Pennsylvania as well as an MBA from the Wharton School of the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Babson Diagnostics
Babson Diagnostics is a medical technology company working to improve customers’ health by making diagnostic blood testing more convenient, accessible, and human. Their proprietary technology is designed to produce accurate diagnostic results from small capillary samples collected at convenient retail locations and analyzed at their CLIA-certified clinical laboratory.